for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

R1 RCM Inc

RCM.OQ

Latest Trade

9.49USD

Change

0.29(+3.10%)

Volume

360,172

Today's Range

9.18

 - 

9.56

52 Week Range

7.42

 - 

13.19

As of on the NASDAQ ∙ Minimum 15 minute delay

Pricing

Previous Close
9.20
Open
9.34
Volume
360,172
3M AVG Volume
20.88
Today's High
9.56
Today's Low
9.18
52 Week High
13.19
52 Week Low
7.42
Shares Out (MIL)
112.15
Market Cap (MIL)
1,063.76
Forward P/E
101.66
Dividend (Yield %)
--

Next Event

R1 RCM Inc Annual Shareholders Meeting

Latest Developments

More

R1 RCM Appoints Richard Evans As Interim CFO

R1 RCM Reports Second Quarter 2019 Results

R1 RCM Reports Q1 Results

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About R1 RCM Inc

R1 RCM Inc. is a provider of revenue cycle management (RCM) and physician advisory services (PAS) to healthcare providers. The Company is engaged in providing management services of revenue cycle operations for the United States-based hospitals and other medical services providers. Its primary service offering consists of end-to-end RCM, which the Company deploys through a co-managed relationship or an operating partner relationship. The Company's PAS offering assists hospitals in complying with payer requirements regarding whether to classify a hospital visit as an in-patient or an out-patient observation case for billing purposes. The Company also provides customers with retrospective appeal management service support for both governmental and commercial payers. Its physicians conduct detailed retrospective reviews of medical records to identify medical necessity for hospital services and the required documentation to support an appeal.

Industry

Business Services

Contact Info

401 N Michigan Ave Ste 2700

+1.312.3247820

http://www.r1rcm.com/

Executive Leadership

Joseph Gerard Flanagan

President, Chief Executive Officer, Director

Richard B. Evans

Interim Chief Financial Officer

Gary Steven Long

Executive Vice President, Chief Commercial Officer

Alex J. Mandl

Lead Independent Director

Anthony R. Tersigni

Director

Key Stats

1.60 mean rating - 5 analysts
Sell
Hold
Buy
Revenue (MM, USD)

2016

0.2K

2017

0.4K

2018

0.9K

2019(E)

1.2K
EPS (USD)

2016

-0.210

2017

-0.750

2018

-0.600

2019(E)

0.093
Price To Earnings (TTM)
--
Price To Sales (TTM)
0.98
Price To Book (MRQ)
241.20
Price To Cash Flow (TTM)
145.72
Total Debt To Equity (MRQ)
172.01
LT Debt To Equity (MRQ)
164.20
Return on Investment (TTM)
-3.67
Return on Equity (TTM)
-2.89

Latest News

Latest News

BRIEF-R1 RCM Inc Reports Q1 Loss Per Share Of $0.26

* QTRLY GAAP NET SERVICES REVENUE OF $147.3 MILLION, UP $60.4 MILLION

BRIEF-R1 Appoints Alex Mandl As Lead Director

* R1 RCM INC - MANDL'S APPOINTMENT FOLLOWS RESIGNATION OF STEVE SHULMAN AS CHAIRMAN OF BOARD, EFFECTIVE APRIL 2 Source text for Eikon: Further company coverage:

BRIEF-R1 RCM Q4 Loss Per Share $0.44

* SEES 2018 GAAP OPERATING LOSS OF $30 MILLION TO $55 MILLION

BRIEF-R1 RCM Says If Deal Terminated Under Certain Circumstances, Co To Pay Intermedix Reverse Termination Fee Of $23 Mln

* R1 RCM SAYS IF DEAL TERMINATED UNDER CERTAIN CIRCUMSTANCES, CO TO PAY INTERMEDIX REVERSE TERMINATION FEE OF $23 MILLION - SEC FILING

BRIEF-Ascension Selects R1 For Physician Practice Revenue Cycle Management

* ASCENSION SELECTS R1 FOR PHYSICIAN PRACTICE REVENUE CYCLE MANAGEMENT

BRIEF-R1 To Acquire Intermedix Corp

* R1 RCM INC - INTERMEDIX EMERGENCY PREPAREDNESS DIVISION IS NOT A PART OF DEAL, WILL BECOME AN INDEPENDENT CO, BACKED BY THOMAS H. LEE PARTNER Source text for Eikon: Further company coverage:

BRIEF-Intermountain Healthcare Selects R1 For Enterprise-Wide Revenue Cycle

* INTERMOUNTAIN HEALTHCARE SELECTS R1 FOR INTEGRATED, ENTERPRISE-WIDE REVENUE CYCLE

BRIEF-R1 RCM Inc Sees 2018 Revenue In Range Of Of $675 Mln- $725 Mln

* R1 RCM INC - SEES 2018 REVENUE IN RANGE OF OF $675 MILLION- $725 MILLION

BRIEF-TCP-ASC ACHI Series LLLP - Exploring With R1 RCM Inc Possible Provision Of Debt, Equity Financing In Connection With Potential Acquisition By Co

* TCP-ASC ACHI SERIES LLLP - EXPLORING WITH R1 RCM INC POSSIBLE PROVISION OF DEBT, EQUITY FINANCING IN CONNECTION WITH POTENTIAL ACQUISITION BY COMPANY Source text: (http://bit.ly/2ApaqPM) Further company coverage:

BRIEF-R1 RCM reports qtrly loss per share ‍$0.08

* R1 RCM Inc qtrly gaap net services revenue of $123.2 million, up $23.8 million sequentially

BRIEF-Litespeed Management reports 5.06 pct passive stake in R1 RCM

* Litespeed Management LLC reports 5.06 percent passive stake in R1 RCM Inc as of August 25 - sec filing Source text : http://bit.ly/2xLFTf9 Further company coverage:

BRIEF-R1 RCM sees FY 2017 revenue $425 mln to $450 mln

* R1 rcm inc - for 2017, r1 currently expects to generate revenue of between $425 million and $450 million

BRIEF-R1 RCM reports Q1 loss per share $0.12

* R1 RCM Inc sees FY 2017 GAAP operating loss in range of $25 million to $30 million

BRIEF-R1 RCM to release Q1 results on May 9

* R1 RCM to release first quarter 2017 results on May 9 Source text for Eikon: Further company coverage:

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up